Researchers
Srdić-Rajić, Tatjana
Results 41-60 of 184
| Issue Date | Title | Author(s) | Type | Мp-cat. |
|---|---|---|---|---|
| 2022 | Rational design and in vitro evaluation of selective inhibitors of cytoplasmic histone deacetylases SIRT2 and HDAC6 | Ružić, Dušan   ; Đoković, Nemanja ; Petković, Miloš ; Gul, Sheraz; Lahtela‐Kakkonen, Maija; Ganesan, A.; Srdić-Rajić, Tatjana ; Nikolić, Katarina | Conference Paper | Mp. category will be shown later |
| 2022 | Rilmenidine binds to and inhibits the activity of MDR pumps in pancreatic ductal adenocarcinoma | Ostojić, Marija ; Đurić, Ana ; Srdić-Rajić, Tatjana ; Dobričić, Vladimir ; Grahovac, Jelena | Conference Paper | Mp. category will be shown later |
| 2022 | Evaluation of the anticancer activity of disulfiram in breast cancer | Ivana Srbljak Ćuk ; Đurić, Ana ; Rajić, Srdić Tatjana | Conference Paper | Mp. category will be shown later |
| 2022 | Expanding the Accessible Chemical Space of SIRT2 Inhibitors through Exploration of Binding Pocket Dynamics | Đoković, Nemanja ; Ružić, Dušan ; Rahnasto-Rilla, Mina; Srdić-Rajić, Tatjana ; Lahtela-Kakkonen, Maija; Nikolić, Katarina | Article | 21aM21a |
| 2021 | Potential anti-MDR effect of rilmenidine in pancreatic ductal adenocarcinoma | Ostojić, Marija ; Pavlović, Marijana ; Srdić-Rajić, Tatjana ; Živić, Kristina ; Jelena Grahovac | Conference Paper | Mp. category will be shown later |
| 2021 | Epigenetic drug discovery: Successful examples of Computer-Aided Drug Designing of Histone Deacetylase (HDAC6 and SIRT2) and Histone Methyltransferase (DOT1L) inhibitors | Ruzic, Dušan ; Đoković, Nemanja B. ; Bon C.; Petkovic, M. ; Ellinger B.; Gul, S.; Santibanez F. J.; Lahtela-Kakkonen, M.; Halby L.; Ganesan, A.;
Srdic-Rajic T.
; Arimondo P.; Nikolić, Katarina M. ; | Conference Paper | Mp. category will be shown later |
| 2021 | SHORT TALK 129 Increased circulating TGF-β1 is associated with impairment in NK cell effector functions in metastatic melanoma patients | Martinovic, Mirjacic Katarina ; Vuletić, Ana ; Mališić, Emina ; Rajić, Tatjana Srdić- ; Miletić, Nevena Tišma ; Babović, Nada ; Jurišić, Vladimir | Conference Paper | Mp. category will be shown later |
| 2021 | Drug repurposing in pancreatic ductal adenocarcinoma | Jelena Grahovac ; Živić, Kristina ; Pavlović, Marijana ; Ostojić, Marija ; Danijel Galun ; Srdić-Rajić, Tatjana | Conference Paper | Mp. category will be shown later |
| 2021 | Nischarin as a target for drug repurposing in solid tumors | Ostojić, Marija ; Pavlović, Marijana ; Živić, Kristina ; Srdić-Rajić, Tatjana ; Jelena Grahovac | Conference Paper | Mp. category will be shown later |
| 2021 | In Vitro Study of Two Edible Polygonoideae Plants: Phenolic Profile, Cytotoxicity, and Modulation of Keap1-Nrf2 Gene Expression | Jovanović, Marina ; Tenji, Dina ; Nikolić, Biljana ; Srdić-Rajić, Tatjana ; Svirčev, Emilija ; Mitić-Ćulafić, Dragana | Article | 21M21 |
| 2021 | Synthesis, molecular modelling and biological characterization of novel antimigratory and antiinvasive 1-benzhydryl piperazine derivatives | Dusan Ruzic ; Milos Petkovic ; E. Bernhard; Sheraz Gul; J.F. Santibanez; Tatjana Srdic Rajic ; Nikolić, Katarina M. | Conference Paper | Mp. category will be shown later |
| 2021 | Nischarin is expressed in pancreatic ductal adenocarcinoma and is a potential target for drug repurposing. | Grahovac, Jelena S ; Pavlovic, Marijana ; Ostojic, Marija Z ; Zivic, Kristina ; Galun, Danijel A; Srdic-Rajic, Tatjana V | Conference Paper | Mp. category will be shown later |
| 2021 | I1-imidazoline receptor ligand inhibits P-glycoprotein efflux in pancreatic ductal adenocarcinoma cells | Ostojić, Marija ; Srdić-Rajić, Tatjana ; Pavlović, Marijana ; Živić, Kristina ; Jelena Grahovac | Conference Paper | Mp. category will be shown later |
| 2021 | Novel 1-benzhydryl piperazine derivative inhibits the migration and invasiveness of breast cancer cells: Synthesis, molecular modelling and biological characterization | Ružić, Dušan ; Petković, Miloš ; Gul, Sheraz; Santibanez, Juan ; Srdić-Rajić, Tatjana ; Nikolić, Katarina | Conference Paper | Mp. category will be shown later |
| 2021 | Potential anti-metastatic activity of Imidazoline I1 receptor agonists in Pancreatic Ductal Adenocarcinoma | Živić, Kristina ; Pavlovic, Marijana ; Ostojić, Marija ; Srdić-Rajić, Tatjana ; Jelena Grahovac | Conference Paper | Mp. category will be shown later |
| 2021 | RATIONAL DESIGN, SYNTHESIS AND IN VITRO TESTING OF - SELECTIVE HDAC6 AND SIRT2 INHIBITORS | Dusan Ruzic ; Đoković, Nemanja B. ; Milos Petkovic ; Danica Agbaba ; Sheraz Gul; Maija Lahtela-Kakkonen; A. Ganesan; Juan F. Santibanez; Tatjana Srdic-Rajic ; Nikolić, Katarina M. | Conference Paper | Mp. category will be shown later |
| 2021 | Anti-migratory properties of Nischarin agonist rilmenidine in pancreatic ductal adenocarcinoma | Živić, Kristina ; Marija Ostojićc; Pavlović, Marijana ; Srdić-Rajić, Tatjana ; Jelena Grahovac | Conference Paper | Mp. category will be shown later |
| 2021 | Rational design, synthesis and in vitro testing of selective HDAC6 and SIRT2 inhibitors | Ružić, Dušan ; Đoković, Nemanja ; Petković, Miloš ; Agbaba, Danica ; Gul, Sheraz; Lahtela‐Kakkonen, Maija; Ganesan, A.; Santibanez, Juan ; Srdić-Rajić, Tatjana ; Nikolić, Katarina | Conference Paper | Mp. category will be shown later |
| 2020 | Paclitaxel inhibits transforming growth factor-beta-increased urokinase-type plasminogen activator expression through p38 MAPK and RAW 264.7 macrophage migration | Mojsilović, Sonja ; Tošić, Milica ; Mojsilović, Slavko ; Živanović, Marija ; Bjelica, Sunčica ; Srdić-Rajić, Tatjana ; Santibanez, Juan | Article | 23M23 |
| 2020 | Potential anti-melanoma activity of Imidazoline I1 receptor agonists | Vidosavljević, Marija Z. ; Tatjana Srdić-Rajić ; Olivera Mitrović-Ajtić ; Marko Jevrić ; Jelena Grahovac | Conference Paper | 34  MNO za medicinske nauke (25.12.2024.)M34 |